Demographics
A total of 482 subjects were screened, and 70 subjects were enrolled and randomized. All of the 70 subjects completed the study. A total of 55 subjects received contezolid acefosamil and were included in safety analysis (IV administration, Disposition of study participants. IV, intravenous; MRX-4, contezolid acefosamil; PK, pharmacokinetic; SAD, single ascending dose.Demographics and baseline characteristics of the study subjectsBMI, body mass index; 